BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 98 filers reported holding BIOSCRIP INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $27,000 | +350.0% | 10,438 | +485.1% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 1,784 | +104.4% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 873 | -2.9% | 0.00% | – |
| Q2 2018 | $3,000 | +200.0% | 899 | +16.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 775 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 775 | -1.6% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 788 | +1.7% | 0.00% | – |
| Q1 2016 | $2,000 | -99.5% | 775 | -99.2% | 0.00% | -100.0% |
| Q1 2015 | $441,000 | -36.6% | 99,518 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $696,000 | +1.2% | 99,518 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $688,000 | -18.3% | 99,518 | -1.4% | 0.00% | 0.0% |
| Q2 2014 | $842,000 | +37.8% | 100,918 | +15.2% | 0.00% | 0.0% |
| Q1 2014 | $611,000 | -18.9% | 87,569 | -14.0% | 0.00% | 0.0% |
| Q4 2013 | $753,000 | -93.0% | 101,770 | -91.6% | 0.00% | -94.1% |
| Q3 2013 | $10,699,000 | +51.6% | 1,218,489 | +184.9% | 0.02% | +30.8% |
| Q2 2013 | $7,056,000 | – | 427,637 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |